Treatment of obstructive airways disease (severe persistent asthma; COPD) and the use of biologics
Alpha-1 antitrypsin deficiency -screening, genetic counseling

To demonstrate commitment to advancing knowledge and skills within specialty area of expertise.
To enhance clinical outcomes through strategic implementation of evidence-based practices.
To pursue opportunities for advancement while embracing creative roles.
Treatment of obstructive airways disease (severe persistent asthma; COPD) and the use of biologics
Alpha-1 antitrypsin deficiency -screening, genetic counseling
2014 Physician Assistants for Global Health Fellow Grant Recipient.
Distinguished Fellow of the American Academy of Physician Assistants, granted 2022.
Speaker Bureau , Sanofi/Regeneron: Selected as a subject matter expert to deliver presentations on the pathophysiology of obstructive airway disease and the use of targeted biologic therapy.